Squarepoint Ops LLC

Position in NVAX — Novavax Inc

CIK 1642575 NEW YORK, NY

Back to NVAX Full portfolio

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,258,154

+$1,258,154 QoQ

Shares Held

133,562

Ownership

0.081%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 263 holders

Holding Since

Mar 2020

20 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Dec 31, 2025

CallValue

$242,592

CallShares

36,100

PutValue

$426,720

PutShares

63,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,789,234 across 255 Biotechnology names. NVAX ranks #101 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

All Filings in NVAX

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,258,154	133,562	+67.7%	Shares	Defined	2026-08-14
2025-12-31	$242,592	36,100	0.0%	Call	Defined	2026-02-13
2025-12-31	$426,720	63,500	-57.8%	Put	Defined	2026-02-13
2025-09-30	$312,987	36,100	0.0%	Call	Defined	2025-11-14
2025-09-30	$1,303,968	150,400	0.0%	Put	Defined	2025-11-14
2025-06-30	$947,520	150,400	-0.5%	Put	Defined	2025-08-27
2025-06-30	$227,430	36,100	0.0%	Call	Defined	2025-08-27
2025-06-30	$501,807	79,652	+38.8%	Shares	Defined	2025-08-27
2025-03-31	$231,401	36,100	-78.4%	Call	Defined	2025-08-27
2025-03-31	$968,551	151,100	-53.7%	Put	Defined	2025-08-27
2025-03-31	$367,837	57,385	-67.4%	Shares	Defined	2025-08-27
2024-12-31	$2,621,040	326,000	+1144.3%	Put	Defined	2025-02-14
2024-12-31	$1,414,967	175,991	+178.6%	Shares	Defined	2025-02-14
2024-12-31	$1,345,896	167,400	+959.5%	Call	Defined	2025-02-14
2024-09-30	$330,906	26,200	+30.3%	Put	Defined	2024-11-14
2024-09-30	$797,950	63,179	-36.0%	Shares	Defined	2024-11-14
2024-09-30	$199,554	15,800	+69.9%	Call	Defined	2024-11-14
2024-06-30	$1,250,516	98,777	-64.8%	Shares	Defined	2024-08-14
2023-09-30	$2,032,072	280,673	+31.7%	Shares	Defined	2023-11-14
2022-12-31	$2,191,325	213,164	+38.0%	Shares	Defined	2023-02-14
2022-09-30	$2,812,082	154,510	-31.5%	Shares	Defined	2022-11-14
2022-06-30	$11,598,390	225,518	+162.9%	Shares	Defined	2022-08-15
2022-03-31	$6,318,654	85,793	+91.1%	Shares	Defined	2022-05-16
2021-12-31	$6,421,553	44,884	+53.9%	Shares	Defined	2022-02-14
2021-12-31	$2,875,707	20,100	0.0%	Put	Defined	2022-02-14
2021-12-31	$1,330,551	9,300	0.0%	Call	Defined	2022-02-14
2021-09-30	$4,166,931	20,100	0.0%	Put	Defined	2021-11-15
2021-09-30	$1,927,983	9,300	-61.4%	Call	Defined	2021-11-15
2021-09-30	$6,047,025	29,169	+50.6%	Shares	Defined	2021-11-15
2021-06-30	$4,112,444	19,370	-21.6%	Shares	Defined	2021-08-16
2021-06-30	$5,116,671	24,100	—	Call	Defined	2021-08-16
2021-06-30	$4,267,431	20,100	—	Put	Defined	2021-08-16
2020-12-31	$2,755,858	24,714	-56.1%	Shares	Defined	2021-02-16
2020-09-30	$6,096,962	56,271	+12.7%	Shares	Defined	2020-11-16
2020-06-30	$4,159,998	49,910	+10.3%	Shares	Defined	2020-08-14
2020-03-31	$614,508	45,251	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.